SCHEMBL7416754

SCHEMBL7416754

Cc1c(Cl)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 8/20 0.74
RET P07949 5/20 0.61
FGFR1 P11362 5/20 0.61
FLT3 P36888 5/20 0.61
FLT1 P17948 4/20 0.61
ALK Q9UM73 4/20 0.61
PDGFRB P09619 4/20 0.61
AURKB Q96GD4 4/20 0.61
CSF1R P07333 3/20 0.61
FGFR3 P22607 3/20 0.61
FLT4 P35916 3/20 0.61
AURKA O14965 3/20 0.61
MAP4K2 Q12851 3/20 0.61
STK3 Q13188 3/20 0.61
SRC P12931 2/20 0.61
MAPK1 P28482 2/20 0.61
ABL1 P00519 2/20 0.61
ZAP70 P43403 2/20 0.61
PLK4 O00444 2/20 0.61
PDPK1 O15530 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7416755 1.00 KDR (0.74) KDRRETFGFR1FLT3FLT1
SCHEMBL13052166 0.87 KDR (0.80) KDRRETFGFR1FLT3FLT1
SCHEMBL5475085 0.85 KDR (1.00) KDRRETFGFR1FLT3FLT1
SCHEMBL5475086 0.85 KDR (1.00) KDRRETFGFR1FLT3FLT1
SCHEMBL6001621 0.84 KDR (0.67) KDRRETFGFR1FLT3FLT1
SCHEMBL6001617 0.84 KDR (0.67) KDRRETFGFR1FLT3FLT1
SCHEMBL5383570 0.80 KDR (0.62) KDRRETFGFR1FLT3FLT1
SCHEMBL5469528 0.80 KDR (1.00) KDRRETFGFR1FLT3FLT1
SCHEMBL5469533 0.80 KDR (1.00) KDRRETFGFR1FLT3FLT1
SCHEMBL6396129 0.80 KDR (0.64) KDRRETFGFR1FLT3FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0769947-B1 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE SUGEN INC (US) 2001-05-02 EP claimed
EP-0769947-A4 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE SUGEN INC (US) 1998-09-30 EP claimed
US-5792783-A CAPABLE OF MODULATING TYROSINE KINASE SIGNAL TRANSDUCTION IN ORDER TO REGULATE, MODULATE AND/OR INHIBIT ABNORMAL CELL PROLIFERATION SUGEN, INC. (US) 1998-08-11 US claimed
EP-0769947-A1 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE Sugen, Inc. (US) 1997-05-02 EP claimed
WO-1996040116-A1 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE SUGEN, INC. (US) 1996-12-19 WO claimed
EP-0769947-B1 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE SUGEN INC (US) 2001-05-02 EP disclosed